The Lustgarten Foundation is the largest private funder of the world’s preeminent pancreatic cancer researchers.
To date, we have funded more than $225 million in research grants and been a leading force in every major advancement in pancreatic cancer research.
Progress is paramount. We drive bold, innovative research with the singular mission: transforming pancreatic cancer into a curable disease.
Read our “Need to Know” summary and watch “Leading the Way: Equity, Accessibility and Diversity in Pancreatic Cancer Research” in its entirety on our YouTube channel.
Lustgarten and the Salk Institute announced a new strategic partnership supported by a $5 million grant and focused on identifying and validating potential targets for new pancreatic cancer drugs.
Solving the unique complexities of pancreatic cancer requires complex thinking and diversity of thought, education,training, background and experience. We are committed to prioritizing and promoting diversity and inclusion acrossthe organization, including staff, volunteer leadership and research portfolio. ResearchA rich field of experience and perspectives working on the complex problems associated with pancreatic cancer increases the […]
News From Lustgarten
Scientists have shown it is possible to reverse a key process that allows pancreatic cancer cells to grow and spread around the body.
Researchers at the Herbert Irving Comprehensive Cancer Center (HICCC) at NewYork-Presbyterian/Columbia University Irving Medical Center have discovered a protein whose level of expression functions as a molecular switch between primary cancer growth and metastatic dissemination in PDA cells.
From Nurse to Patient
When Susan was diagnosed with pancreatic cancer, cutting-edge drugs and a supportive medical team helped her go from patient to survivor. Now she raises funds for continued research through a Lustgarten Foundation Walk for Research.Read Susan’s Story